TECH Ключевая статистика
Максимум
72.12
Открыть
71.60
Объем
3.07M
Минимум
71.50
Предыдущее закрытие
71.77
Объем торгов
221.03M
Макс. 52 нед.
72.16
Отн. объем
0.367
Амплитуда (%)
0.86%
Мин. 52 нед.
43.20
Коэф. оборота
1.96%
Рыночная капитализация
11.18B
P/E (TTM)
103.59
P/E (год.)
153.447
P/B
5.39
P/S
9.28
Прибыль на акцию (EPS)
0.696
Дивиденд (TTM)
0.317
Дивидендная доходность
0.45%
Акции в обращении
156.56M
Валюта
USD
TECH Доходность цены
7 день
30 день
90 день
180 день
С начала года
1 Год
TECH Распределение денежных потоков
TECH Дневной объем коротких продаж
TECH История short interest
Обзор акции TECH
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59.
On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH ближе к верхней границе its most recent trading range.
Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is значительно ниже обычного уровня than usual.
Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
TECH Связанные новости
О нас TECH
Название компании
Bio-Techne Corp
Сектор
Health Technology
Отрасль
Biotechnology
Биржи
Nasdaq
Количество сотрудников
3,100
Размер лота
100
Официальный сайт
Валюта
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Related Stocks
© 2026 CoinGlass, all rights reserved
